Micropharma’s cholesterol-busting probiotic ready for US food, beverage and supplements market
With ten years of work behind it, two clinical trials (plus results of a third ready for publication), and Groupe Danone on-board, Canada’s Micropharma is rolling out its cholesterol-lowering Lactobacillus reuteri NCIMB 30242 for the US supplement, food...